439 related articles for article (PubMed ID: 28368950)
1. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
Maura G; Chaignot C; Weill A; Alla F; Heard I
Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
[TBL] [Abstract][Full Text] [Related]
2. Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.
Qin J; Shahangian S; Saraiya M; Holt H; Gagnon M; Sawaya GF
Gynecol Oncol; 2021 Nov; 163(2):378-384. PubMed ID: 34507826
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
4. Population-based organized cervical cancer screening pilot program in France.
Hamers FF; Duport N; Beltzer N
Eur J Cancer Prev; 2018 Sep; 27(5):486-492. PubMed ID: 28362653
[TBL] [Abstract][Full Text] [Related]
5. Differences in cervical cancer screening and follow-up for black and white women in the United States.
Ford S; Tarraf W; Williams KP; Roman LA; Leach R
Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
[TBL] [Abstract][Full Text] [Related]
6. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
White MC; Shoemaker ML; Benard VB
Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France.
de Rycke Y; Tubach F; Lafourcade A; Guillo S; Dalichampt M; Dahlab A; Bresse X; Uhart M; Bergeron C; Borne H; Cancalon C; Lajoinie A; Bénard S
PLoS One; 2020; 15(2):e0228660. PubMed ID: 32053648
[TBL] [Abstract][Full Text] [Related]
9. Cervical Screening and Colposcopy Management of Women Age 24 and Under.
Buick C; Jembere N; Wang L; Kupets R
J Obstet Gynaecol Can; 2020 Dec; 42(12):1518-1524. PubMed ID: 32988802
[TBL] [Abstract][Full Text] [Related]
10. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
Miller RA; Waters LL; Mody DR; Tams KC
Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
[TBL] [Abstract][Full Text] [Related]
12. Cervical Cancer in Women with Normal Papanicolaou Tests: A Korean Nationwide Cohort Study.
Kim M; Kim H; Suh DH; Kim YB
Cancer Res Treat; 2021 Jul; 53(3):813-818. PubMed ID: 33321565
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
Coldman A; van Niekerk D; Smith L; Ogilvie G
J Med Screen; 2017 Dec; 24(4):195-200. PubMed ID: 27810984
[TBL] [Abstract][Full Text] [Related]
14. Cervical testing beyond the screening target age - A register-based cohort study from Finland.
Keltto N; Leivonen A; Pankakoski M; Sarkeala T; Heinävaara S; Anttila A
Gynecol Oncol; 2021 Aug; 162(2):315-321. PubMed ID: 34074539
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort.
Kamineni A; Tiro JA; Beaber EF; Silverberg MJ; Wheeler CM; Chao CR; Chubak J; Skinner CS; Corley DA; Kim JJ; Balasubramanian BA; Paul Doria-Rose V;
Int J Cancer; 2019 Mar; 144(6):1460-1473. PubMed ID: 30353911
[TBL] [Abstract][Full Text] [Related]
16. Organised screening for cervical cancer in France: a cost-effectiveness assessment.
Barré S; Massetti M; Leleu H; De Bels F
BMJ Open; 2017 Oct; 7(10):e014626. PubMed ID: 28988162
[TBL] [Abstract][Full Text] [Related]
17. A decade has passed...the Pap smear and cervical cancer.
Linder J
Am J Clin Pathol; 1997 Nov; 108(5):492-8. PubMed ID: 9353086
[No Abstract] [Full Text] [Related]
18. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.
Katz ML; Zimmermann BJ; Moore D; Paskett ED; Reiter PL
Women Health; 2017; 57(10):1161-1177. PubMed ID: 27700693
[TBL] [Abstract][Full Text] [Related]
19. Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial.
Gizaw M; Teka B; Ruddies F; Abebe T; Kaufmann AM; Worku A; Wienke A; Jemal A; Addissie A; Kantelhardt EJ
Cancer Prev Res (Phila); 2019 Sep; 12(9):609-616. PubMed ID: 31337647
[TBL] [Abstract][Full Text] [Related]
20. Community-Based Screening for Cervical Cancer: A Feasibility Study of Rural Appalachian Women.
Crosby RA; Hagensee ME; Vanderpool R; Nelson N; Parrish A; Collins T; Jones N
Sex Transm Dis; 2015 Nov; 42(11):607-11. PubMed ID: 26462184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
